T8	Treatment 41 48	quinine
T9	Effect 77 119	reverse P-glycoprotein-mediated resistance
T11	Speculation_cue 185 192	whether
T13	Subject 231 263	adult patients (15-60 years old)
T14	Age 231 236;247 262	adult 15-60 years old
T15	Drug 41 48	quinine
T16	Treat-Disorder 269 309	de novo acute myelogenous leukemia (AML)
